Download 2000

LIST OF PUBLICATIONS
ANNE-LISE BØRRESEN-DALE
2009- 2013
Original articles
2009
323. Dunning, A.M., Healey CS, Baynes C, Scollen S, Vega A, Rodríguez R, Maia AT, Ponder BA, Low
YL, Bingham S, Haiman CA, Le Marchand L, ..............., Børresen-Dale, A.-L., Kristensen V,
Hunter DJ, Hankinson SE, Devillee P, Vreeswijk M, Lissowska J, Brinton L, Liu J, Hall P, Kang D,
Yoo KY, Shen CY, Yu JC, Anton-Culver H, Ziogoas A, Sigurdson A, Struewing J, Easton DF,
Humphreys M, Morrison J, Pharoah PD, Pooley K, Chenovix-Trench G. Association of ESR1 genet
tagging SNPs with breast cancer risk. Hum Mol Genet 15;18(6):1131-9, 2009.
324. Zhou, W., Muggerud, A., Vu, P., Due, E. U., Sørlie, T., Børresen-Dale, A.-L., Wärnberg, F. and
Langerød, A.: Full sequencing of TP53 identifies identical mutations within in situ and invasive
components in breast cancer suggesting clonal evolution. Mol Oncol. 3(3): 214-219, 2009.
325. Murph, M., Liu, W., Yu, S., Lu, Y., Hall, H., Hennessy, B., Lahad, J., Schaner, M., Helland, Å.,
Kristensen, G., Børresen-Dale, A.-L. and Mills, G.: Lysophosphatidic acid-induced transcriptional
profile represents serous epithelial ovarian carcinoma and worsened prognosis.
PLoS ONE. 4(5):e5583, 2009.
326. Kamalakaran, S., Kendall,J., Zhao,X., Tang, C., Khan, S., Ravi, K., Auletta, T., Riggs, M., Wang,Y.,
Helland, Å., Naume,B., Dimitrova, N., Børresen-Dale, A.-L., Hicks, J., and Lucito, R.: Methylation
detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island
methylation. Nucleic Acids Res. 37(12):e89, 2009.
327. Glynn SA, Boersma BJ, Howe TM, Edvardsen H, Geisler SB, Goodman JE, Ridnour LA, Lønning PE,
Børresen-Dale, A.-L., Naume B, Kristensen VN, Chanock SJ, Wink DA, Ambs S: A mitochondrial
target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in
breast cancer patients treated with cyclophosphamide. Clin Cancer Res. 15;15(12):4165-73, 2009.
328. Landmark-Høyvik H, Reinertsen KV, Loge JH, Fosså SD, Børresen-Dale, A.-L., Dumeaux V.
Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer
survivors. Pharmacogenomics J. 9(5):333-40, 2009.
329. Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K,
Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale
A.-L., Mills GB, Hennessy BT.: Integrative analysis of cyclin protein levels identifies cyclin B1 as a
classifier and predictor of outcomes in breast cancer. Clin Cancer Res. 2009 Jun 1;15(11):3654-62,
2009.
330. Leivonen, S.-K., Mäkelä, R., Östling, P., Kohonen, P., Haapa-Paananen, S., Kleivi, K., Enerly,
E., Aakula, A., Hellström, K., Sahlberg, N., Kristensen, V. N., Børresen-Dale, A.-L., Saviranta, P.,
Perälä, M. and Kallioniemi, O.: Protein lysate microarray analysis to identify microRNAs regulating
estrogen receptor signaling in breast cancer cell lines. Oncogene. 5;28(44):3926-36, 2009.
331. Bergamaschi, A., Hjortland, G. O., Triulzi, T., Johnsen, H., Ree, A. H., Trones, S., Mellandsmo, G.,
Fodstad, Ø., Børresen-Dale, A.-L. and Engebråten, O.: Molecular profiling and characterization of
luminal-like and basal-like in vivo breast xenograft models. Mol Oncol.;3(5-6):469-82, 2009.
332. Stephens, P. J., McBride, D. J., Lin, M.-L., Varela, I., Pleasance, E. D., Simpson, J. T., Stebbings, L.
A., Leroy, C., Edkins, S., Mudie, L. J., Greenman, C. D., Jia, M., Latimer, C., Teague, j., W. Burton,
J., Quaile, M. A., Swerdlow, H., Natrajan, R., Sieuwerts, A. M., Martens, J. W. M., Silver, D. P.,
Langerød, A., Russnes, H.E.G., Foekens, J. a., Reis-Filho, J. S., van’t Veer, L, Richardsson, A. L.,
Børresen-Dale, A.-L., Campbell, P. J., Futreal, P. A. and Stratton, M. R.: Complex landscapes of
somatic rearrangement in human breast cancer genomes. Nature, 462(7276):1005-10, 2009.
03.05.2017
1
333. Bocanegra, M., Bergamaschi, A., Kim, Y. H., Miller, M. A., Rajput, A. B., Kao, J., Langerød, A., Han,
W., Noh, D. Y., Jeffrey, S. S., Huntsman, D. G., Børresen-Dale, A.-L. and Pollack, J. R.: Focal
amplification and oncogene dependency of GAB2 in breast cancer. Oncogene, 4(29): 774-9, 2010.
2010
334. Aarøe, J., Lindahl, T., Dumeaux, V., Sæbø, S., Tobin, D., Hagen, N., Skaane, P.,Lönneborg, A.,
Sharma, P. and Børresen-Dale, A.-L.: Gene expression profiling of peripheral blood cells for early
detection of breast cancer. Breast Cancer Res. 12(1):R3, 2010.
335. Muggerud, A. Aa., Rønneberg, J. A., Wärnberg, F., Botling, J., Busato, F., Jovanovic, J., Solvang, H.,
Bukholm, I., Børresen-Dale, A.-L., Kristensen, V. N., Sørlie, T. and Tost, J.: Frequent aberrant
DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early
invasive breast cancer. Breast Cancer Res. 12(1):R7, 2010.
336. Potapenko, I. O., Haakensen, V. D., Lüders, T., Helland, Å., Bukholm, I. R., Sørlie, T., Kristensen, V.
N., Lingjærde, O. C. and Børresen-Dale, A.-L.: Glycan gene expression signatures in
normal and malignant breast tissue; possible role in diagnosis and progression. 2009. Molecular
Oncol. 4(2):98-118, 2010.
337. Figueiredo, J. C, Haile, R. W., Bernstein, L., Malone, K. E., Largent, J., Langholz, B., Lynch, C. F.,
Bertelsen, L., Capanu, M., Concannon, P., Borg, Å., Børesen-Dale, A.-L. et al. WECARE study
collaborative group and Bernstein, J.: Oral contraceptives and post-menopausal hormones and risk
of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and non-carriers: The
WECARE study. Breast Cancer Res Treat. 120: 175-183, 2010.
338. Neergaard de, M., Kim, J., Viladsen, R., Fridriksdottir, A. J., Rank, F., Timmermans-Wielenga, V.,
Langerød, A., Børresen-Dale, A.-L., Petersen, O. W. and Rønnov-Jessen, L.: Epithelial-Stromal
interaction 1 (EPsTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment. Am. J.
Pathol. 176(3): 1229-40, 2010.
339. Borg, Å., Haile, R. W., Malone, K. E., Capanu, M., Diep, A., Törngren, T., Teraoka, S., Begg, C. B.,
Thomas, D. C., Cannon, P., Mellemkjaer, L., Bernstein, L., Tellhed. L., Xue, S., Olson, E. R., Liang,
X., Dolle, J., Børresen-Dale, A.-L., Bernstein, J. L. The WECARE study group.: Characterization
of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in
unilateral and bilateral breast cancer: Hum. Mutation. 31(3):1229-40., 2010.
340. Bernstein, J., Haile, R. W., Stovall, M., Boice, J., Shore, R., Langholz, B., Thomas, D.,Bernstein, L.,
Lynch, C., Olsen, J. H., Malone, K., Mellemkjaer, L., Børresen-Dale, A.-L., Rosenstein, B.,
Teraoka, S., Diep, AT., Smith, S., Capanu, M., Reiner, A., Liang, X., Gatti, R., Concannon, P.: The
WECARE Collaborative Study Group and Concannon, P.: Radiation exposure, the ATM gene, and
contralateral breast cancer in the women’s environmental cancer and radiation epidemiology study.
WECARE study. JNCI 102(7): 475-83, 2010.
341. Dumeaux, V., Olsen, K. S., Nuel, G., Paulssen, R. H., Børresen-Dale, A.-L. and Lund, E.: Deciphering
normal blood gene expression variation – The NOWAC postgenome study. PlosGenet: 6(3):
e1000873, 2010
342. Dejeux, E., Rønneberg, J. A., Solvang, H., Bukholm, I., Geisler, S., Aas, T., Gut, I. G., Børresen-Dale,
A.-L., Lønning, P. E., Kristensen, V. N. and Tost, J.: DNA methylation profiling in doxorucibin
treated primary locally advanced breast tumors identifies novel predictive biomarkers for survival
and treatment response. Mol. Cancer 9(1): 68, 2010.
343. Fu, Y-P., Edvardsen, H., Kaushiva, A., Arhancet, J., Howe, T. M., Kohaar, I., Porter-Gill, P., Shah, A.,
Landmark-Høyvik, H., Fosså, S. D., Ambs, S., Naume, B., Børresen-Dale, A.-L., Kristensen, V. N.
and Prokunina-Olsson, L.: NOTCH2 in breast cancer: association of SNP rs11249433 with gene
expression in ER-positive breast tumors without TP53 mutations. Mol. Cancer 9(1): 113, 2010.
03.05.2017
2
344. Edvardsen, H., Brunsvig, P. Solvang, H., Tsalenko, A., Andersen, A.,Fr., Syvanen, A.-C., Ykahini, Z.,
Børresen-Dale, A.-L., Olsen, H., Aamdal, S. and Kristensen, V. N.: SNPs in genes coding for ROS
metabolism and signalling in association with docetaxel clearance.
Pharmacogenomics Pharmacogenomics J. [Epub ahead of print]PMID: 20157331
345. Landmark-Høyvik, H. B., Reinertsen, K., Loge, J. H., Kristensen, V. N., Duemaux, V., Fosså, S. D.,
Børresen-Dale, A.-L. and Edvardsen, H.: The genetics and epigenetics of fatigue. J. of Physical
Medium and Rehabilitation. 2(5):456-65, 2010.
346. Russnes, H. G., Vollan, H. K. M., Lingjærde, O. C., Krasnitz, A., Lundin, P., Naume, B., Sørlie, T.,
Borgen, E., Rye, I. H., Langerød, A., Chin, S-F., Teschendorff, A. E., Stephens, P. J., Månèr, S.,
Schlichting, E., Baumbusch, L. O., Kåresen, R., Stratton, M. P., Wigler, M., Caldas, C., Zetterberg,
A., Hicks, J. and Børresen-Dale, A.-L.: Genomic architecture characterizes tumor progression paths
and fate in breast cancer patients. Science Transl Med. 2(38):38ra47, 2010.
347. Avraham, R., Sas-Chen, A., Manor, O., Steinfeld, I., Shalgi, R., Tarcic, G., Bossel, N., Zeisel, A, Amit,
I., Zwang, Y., Enerly, E., Russnes, H. G., Biagioni, F., Mottolese, M., Strano, S., Blandino, G.,
Børresen-Dale, A.-L., Pilpel, Y., Yakhini, Z., Segal, E. and Yarden, Y.: EGF decreases the
abundance of microRNAs that restrain oncogenic transcription factors.
Science Signal. 1;3(124):ra43, 2010.
348. Haakensen, V. D., Biong, M., Lingjærde, O.C., Holmen, M. M., Frantzen, J. O., Chen, Y., Navjord, D.,
Romundstad, L., Lüders, T., Bukholm, I., Solvang, H. K., Kristensen, V. N., Ursin, G., BørresenDale, A.-L. and Helland, Å.: Expression levels of uridine 5'- diphospho-glucuronosyltransferase
genes in breast tissue from healthy women are associated with mammographic density.
Breast Cancer Res. 27;12(4):R65, 2010.
349. Muggerud, Aa., Sørlie, T., Hallett, M., Johnsen, H., Kleivi, K., Zhou, W., Tahmasebpoor, S.,
Amini, R.-M., Botling, J., Børresen-Dale, A.-L., Sørlie, T. and Wärnberg, F.:
Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.
Mol Oncol. (4):357-68, 2010.
350. Berge, EO., Knappskog, S., Geisler, S., Staalesen, V., Pacal, M., Børresen-Dale, A.-L., Puntervoll,
P., Lillehaug, J.R. and Lønning, P.E.: Identification and characterization of retinoblastoma gene
mutations disturbing apoptosis in human breast cancers. Mol Cancer.9:173, 2010
351. Sørlie, T., Borgan, E., Myhre, S., Vollan, H.K., Russnes, H., Zhao, X., Nilsen, G., Lingjaerde, O.C.,
Børresen-Dale A..-L., and Rødland, E.: The importance of gene-centring microarray data.. Lancet
Oncol. 2010 Aug;11(8):719-20, 2010.
352. Hennessy, B. T., Lu, Y., Gonzalez-Angulo, A.M., Carey , M. S., Myhre, S., Ju, Z., Davies, M. A., Liu,
W., Coombes, K., Meric-Bernstam, F., Bedrosian, I., McGahren, M., Agarwal, M., Zhang, F.,
Overgaard, J., Alsner, J., Neve, R. M., Kuo, W.-L., Gray, J. W. , Borresen-Dale, A.-L. and Mills,
G. B.: A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the
Functional Proteome in Non-microdissected Human Breast Cancers. Clin.Proteom 6:129-151, 2010.
353. Van Loo, P., Nordgard, S. H., Lingjærde, O. C., Russnes, H. G., Rye, I. H., Sun, W., Weigman, V. J.,
Marynen, P., Zetterberg, A., Naume, B., Perou, C. M., Børresen-Dale, A.-L. and Kristensen, V. N.:
Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A. 2010 Sep
28;107(39):16910-5.
354. Moestue, S. A., Borgan, E., Huse, E. M., Lindholm, E. m., Sitter, B., Børresen-Dale, A.-L.,
Engebraaten, O., Mælandsmoe, G. M. and Gribbestad, I. S.: Distinct choline metabolic profiles are
associated with differences in gene expression for basal-like and luminal-like breast cancer
xenograft models.BMC Cancer. 10:433, 2010.
355. Landmark-Høyvik, H., Dumeaux, V., Reinertsen, K. V., Edvardsen, H., Fosså, S. D. and Børresen-
Dale, A.-L.: Blood gene expression profiling of breast cancer survivors experiencing fibrosis. In. J.
Radiation Oncol. Biol. Physics. 2010 Dec.
03.05.2017
3
356. Borgan, E., Sitter, B., Lingjærde, O. C., Johnsen, H., Lundgren, S., Bathen, T. F., Sørlie, T., BørresenDale, A.-L. and Gribbestad, I. S.: Merging transcriptiomics and meabolomics – advances in breast
cancer profiling. BMC Cancer. Nov.16;10:628.
357. Holstege, H., Hørlings, H., Velds, A., Langerød, A., Børresen-Dale, A.-L., van de Vijver, M. J.,
Nederlof, P. and Jonkers, J.: BRCA1-mutated and basal-like breast cancers share molecular
characteristics. BMC Cancer 2010 Nov.30;10(1):169
358. Myhre, S., Mohammed, H.,Tramm, T., Alsner, J., Overgaard, J., Børresen-Dale, A.-L., Frigessio, A.
and Sørlie, T.: In Silico ascription of gene expression differences to tumor and stromal cells in a
model to study impact on breast cancer outcome. Plos One. 2010 Nov 19;5(11):e14002
359. Papp, J.,Kovacs, M.E., Solyom, S., Kasler M., Børresen-Dale, A.L., Olah E.: High prevalence og
germline STK11 mutations in Hungarian Peutz-Jeghers Syndrome patients. BMC Med Genet. 2010
Nov.30:11(1)169
2011
360. Edgren H, Murumägi A, Kangaspeska S, Nicorici D, Hongisto V, Kleivi K, Rye IH, Wolf M,
Børresen-Dale, A.-L. and Kallioniemi O.: Identification of fusion genes in breast cancer by pairedend RNA-sequencing. Genome Biology, 2011 jan.19:12(1):R6
361. Rønneberg, J. O., Fleischer, T., Solvang, H. K., Nordgard, S. H., Edvardsen, H., Potapenko, I., Nebdal,
D., Daviaud, C., Gut, I., Bukholm, I. K., Naume, B., Børresen-Dale, A.-L., Tost, J. and Kristensen,
V. N.: Methylation profiling of a panel of cancer related genes: Association with estrogen receptor,
TP53 mutation status and expression subtypes in sporadic breast cancer.
Mol. Onc.2011 Feb;5(1):61-76
362. Kamalakaran, S., Varadan, V., Russnes, H. G. R., Levy, D., Kendall, J., Janevski, A., Rigs, M.,
Banerjee, N., Synnestvedt, M., Schlichting, E., Kåresen, R, Prasada, S, Rotti, H., Rao, R, Rao, L.,
Satayamoorthy, K., Lucito, R., Wigler, M., Dimitrova, N., Naume, B., Børresen-Dale, A.-L. and
Hicks, J. B.: DNA methylation patterns in breast cancer are subtype specific and can identify relapse
risk independent of other clinical variables. Mol Onc.2011 Feb;5(1):77-92
363. Knappskog, S., Bjørnslett, M., Myklebust, L, M., Huijts, P., Vreeswijk, M. P., Edvardsen, H., Guo, Y.,
Zhang, G., Yang, M., Ylisaukko-oja, S. K., Alhopuro, P., Arola, J., Tollenaar, R. A.E.M., van
Asperen, C. J. , Seynaeve, C., Staalesen, V., Chiranthar, R., Løkkevik, E., Lin, D., Aaltonen, L. A.,
Børresen-Dale, A.-L., Vatten, L., Hveem, K., Lillehaug, J. R., Dørum, A., Devilee, P. and Lønning,
P. E.: the MDM” promoter SNP285/309G haplotype reduces risk for breast and ovarian cancer in
Caucasians. Cancer Cell, 2011 Feb.15;19(2):273-82
364. Enerly, E., Steinfeld, I., Kleivi, G. K., Leivonen, S. K., Aure, M. R., Russnes, H. G., Rønneberg, J. O.,
Johnsen, H., Navon, R., Rødland, E., Mäkalä, R., Naume, B., Perälä, M., Kallioniemi, O.,
Kristensen, V. N., Yakhini, Z. and Børresen-Dale, A.-L.: miRNA-mRNA integrated analysis
reveals roles for miRNAs in primary breast tumors. Plos One, 2011 Feb 22:6 (2) e16915
Enerly E, Steinfeld I, Kleivi K, Leivonen SK, Aure MR, Russnes HG, Rønneberg JA, Johnsen H,
Navon R, Rødland E, Mäkelä R, Naume B, Perälä M, Kallioniemi O, Kristensen VN, Yakhini Z,
Børresen-Dale AL. Correction: miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in
Primary Breast Tumors. PLoS One. 2013 Sep 10;8(9). doi: 10.1371/annotation/a20454a7-ddc44657-b73c-185bd6ec6977.
365. Russnes, H. G., Kuligina, E. Sh., Suspitsin, E. N., Jordanova, E. S., Cornelisse, C. J., Børresen-Dale,
A.-L. and Imyanitov, E. N.: Paired distribution of molecular subtypes in bilateral breast carcinomas.
Cancer Genetics 2011 Feb Vol.204 (2) p.96-102
366. Zhao X, Rødland EA, Sørlie T, Naume B, Langerød A, Frigessi A, Kristensen VN, Børresen-Dale, A.L., and Lindgjærde OC.: Combining gene signatures improves prediction of breast cancer survival.
PLoS One, 2011 Mar.10;6(3) e17845
03.05.2017
4
367. Westbury C.B., Sahlberg K.K., Børresen-Dale A.-L., Isacke C.M. and Yarnold J.R.:
Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does
not differentiate between radiation sensitive and control patients.
Radiation Oncology, 2011 Apr.26:6(1):42
368. Helland, Å., Anglesio, M. S., George, J., Cowin, P. A., Johnstone, C. N., House, C. M., Sheppard, K.
E., Etemadmoghadam, , D., Melnyk, N., Rustgi, A., K., Phillips, W. A., Johnsen, H., Holm, R.,
Kristensen, G. B., Australian Ovarian Study Group, Pearson, R. B., Børresen-Dale, A.-L.,
Hunstman, D. G., DeFazio, A., Creighton, C. J., Smyth, G. K. and Bowtell, D. D.L.: MYCN, Let-7
and HMGA2 copy number change and altered gene expression in a specific molecular subtype of
high-grade serous ovarian cancer. PLoS One, April 2011 Vol.6, Issue 4 e18064
369. Solvang HK, Lingjærde OC, Frigessi A, Børresen-Dale A.-L., and Kristensen VN.:
Linear and non-linear dependencies between copy number aberrations and mRNA expression reveal
distinct molecular pathways in Breast Cancer. BMC Bioinformatics 2011, May 24;12(1)197
370. Broeks A., Schmodt M.K., Sherman M.E., Couch F.J. et al…… Alnæs G.G., Kristensen V.N,
Børresen-Dale A.-L., …. Pharoah P.D.P., Garcia-Closas M.: Low penetrance breast cancer
susceptibility loci are associated with specific breast tumor subtypes: Findings from the
Breast Cancer Association Consortium. Hum Mol Genet. 2011 Aug 15;20(16):3289-303. Epub 2011
May 19.
371. Hung T, Wang Y, Lin MF, Kooegel A, Kotake Y, Grant G, Horlings HM, Shah N, Umbricht C,
Wang P, Wang Y, Langerød A, Børresen-Dale A.-L., Kim, SK, van de Vijver M, Sukumar, S,
Whitfield ML, Kellis M, Xiong Y, Wong D. and Chang HY.: Extensive and coordinated
transcription of noncoding RNAs within cell cycle promoters. Nat Genet. 2011 Jun 5;43(7):621-9.
doi: 10.1038/ng.848
372. Akslen LA, Straume O, Geisler S, Sørlie T, Chi J-T, Aas T, Børresen-Dale, A.-L., and
Lønning PE; Glomeruloid microvascular proliferation is associated with lack of response to
chemotherapy in breast cancer. Br J Cancer. 2011 Jun 28;105(1):9-12.
373. Gonzales-Angulo, A. M., Hennessy, B. T., Meric-Bernsta, F., Sahin, A., Liu, W., Ju, Z., Carey, M. S.,
Myhre, S., Speers, C., Deng, L., Boraddus, R., Lluch, A., Aparicio, S., Brown, P., Pusztai, W.,
Symmans, F., Alsner, J., Overgaard, J., Børresen-Dale, A.-L., Hortobagyi, G. N., Coombe, K. R.
and Mills, G. B.: Functional proteomics can define prognosis and predict pathological complete
response in breast cancer. Clin Proteomics. 2011 Jul 8;8(1):11.
374. Haakensen,V.D., Bjøro, T., Lüders, T., Riis,M., Bukholm,I.K., Kristensen, V.N., Troester, M.A.,
Holmen M.M., Ursin, G., Børresen-Dale, A.-L. and Helland, Å.: Serum estradiol levels associated
with specific gene expression patterns in normal breast tissue and in breast carcinomas.
BMC Cancer 2011 Aug 3;11(1):332
375. Borgan, E.,Navon, R., Vollan, H.K., Schlichting, E., Sauer, T., Yakhini, Z., Lindgjære, O.C., Sørlie, T.
and Børresen-Dale, A.-L.: Ischemia caused by time to freezing induces systematic microRNA and
mRNA responses in cancer tissue. Mol Oncol. 2011 Dec;5(6):564-76.
376. Kristensen, V.N., Vaske, C.J.,Ursine-Siegel, J., Van Loo, P., Nordgard, S.H., Sachidanandam, R.,
Sørlie.,T., Wärnberg, F., Haakensen, V.D., Helland, Å., Naume, B., Perou, C.M., Haussler, J.D.,
Troyanskaya, O.and Børresen-Dale, A.-L.: Integrated Molecular Profiles of Invasive Breast Tumor
and DCISs Reveal Differential Vascular and Interleukin Signaling. Proc Natl Acad Sci U S A. 2011
Sep 9. [Epub ahead of print] 2012 Feb 21;109(8):2802-7.
377. Mathiesen RR, Fjelldal R, Liestøl K, Due EU, Geigl JB, Riethdorf S, Borgen E, Rye IH, Schneider IJ,
Obenauf AC, Mauermann O, Nilsen G, Lingjærde OC, Børresen-Dale, A.-L., Pantel K, Speicher
MR, Naume B, Naumbusch LO.: High-resolution analyses of copy number changes in disseminated
tumor cells of patients with breast cancer. Int J Cancer, 131 (4), E405-15, 2012.
03.05.2017
5
378. Milne R.L., Goode E.L., Garcia-Closas M., Couch F.J. et al…… Alnæs G.G., Kristensen V.N,
Børresen-Dale A.-L., …..Chenevix-Trench G. Easton D.F.: Confirmation of 5p12 as a
susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol
Biomarkers Prev. 2011 Oct;20(10):2222-31. Epub 2011 Jul 27
379. Russnes HG, Navin N, Hicks J, Børresen-Dale, A.-L.: Insight into the heterogeneity of breast cancer
through next-generation sequencing. J.Clin Invest. 2011 Oct 3:121(10):3810-8
380. Haakensen V.D., Lingjærde O.C., Lüders T., Riis M., Prat A., Troester M.A., Holmen M.M., Frantzen
J.O., Romundstad L., Navjord D., Bukholm I.K., Johansen T., Perou C.M., Ursin G., Kristensen V.N.,
Børresen-Dale A.-L., Helland Å.: Gene expression profiles of breast biopsies from healthy women
identify a group with claudin-low features. BMC Med Genomics. 2011 Nov 1;4:77
381. Weigman VJ, Chao H-H, Shabalin AS, He X, Parker JS, Nordgard S, Grushko T, Huo D, Nwachukwu
C, Nobel A, Kristensen VN, Børresen-Dale, A.-L., Olopade OI, and Perou CM; Basal-like Breast
cancer DNA copy number losses identify genes involved in genomic instability, response to therapy,
and patient survival. Breast Cancer Res Treat, 133 (3), 865-80.
382. Kaveh F, Edvardsen H, Børresen-Dale, A.-L., Kristensen VN, Solvang HK.: Allele-specific disparity
in breast cancer. BMC Med Genomics. 2011 Dec 21;4(1):85. [Epub ahead of print]
383. Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, Lynch CF, Malone KE, Stovall M,
Capanu M, Liang X, Smith SA, Mychaleckyj J, Hou X, Mellemkjaer L, Boice JD Jr, Siniard A,
Duggan D,Thomas DC; WECARE Study Collaborative Grou, Børresen-Dale, A.-L.,Concannon P.
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's
Environment, Cancer, and Radiation Epidemiology (WECARE) Study. Breast Cancer Res.
2011;13(6):R114. Epub 2011 Nov 17.
384. Borge KS, Børresen-Dale A.-L, Lingaas F: Identification of genetic variation in 11 candidate genes of
canine mammary tumour. Vet Comp Oncol. 2011 Dec;9(4):241-50. doi: 10.1111/j.14765829.2010.00250.x. Epub 2011 Jan 17.
2012
385. Stevens K, Fredericksen Z, Vachon C, Wang X, Margolin S, Lindblom A, Nevanlinna H, Greco D,
Aittomäki K, Blomqvist C, Chang-Claude J, Vrieling A, Flesch-Janys D, Sinn HP, Wang-Gohrke S,
Nickels S, Brauch H, Ko YD, Fischer H, The GENICA Network….. Børresen-Dale, A.-L.,….Soini
Y, Easton D,and Couch F.: 19p13.1 is a triple negative-specific breast cancer susceptibility locus.
Canc.Res2012 Apr 1;72(7):1795-803, 2012.
386. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J, Wang Q,
Humphreys MK, Luccarini C, Baynes C, Conroy D, Maranian M, Ahmed S, Driver K, Johnson N,
Orr N, Silva IdS, Waisfisz Q, Meijers-Heijboer H, Uitterlinden AG, Rivadeneira F, HEBON, Hall P,
Czene K,…..Alnæs, GIG, Kristensen, VN, Børresen-Dale, A.-L., Rahman N, Peto J, Easton DF et
al: Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nature
Genetics 22;44(3):312-8, 2012.
387. Freed-Pastor WA, Mizuno H, Zhao X, Langerød A, Moon SH, Rodriguez-Barrueco R, Barsotti A,
Chicas A, Li W, Polotskaia A, Bissell MJ, Osborne TF, Tian B, Lowe SW, Silva JM, Børresen-Dale
A.-L., Levine AJ, Bargonetti J and Prives C; Mutant p53 Disrupts Mammary Tissue Architecture via
the Mevalonate Pathway. Cell.;148(1-2):244-58, 2012.
388. Kim J, Villadsen R, Sørlie T, Fogh L, Grønlund SZ, Fridriksdottir AJ, Kuhn I, Rank F, Wielenga VT,
Solvang H, Edwards PA, Børresen-Dale A.-L, Rønnov-Jessen L, Bissell MJ, Petersen OW.: Tumor
initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of
basal-like activity. Proc Natl Acad Sci U S A.;109(16):6124-9, 2012.
03.05.2017
6
389. Joshi, H., Nord, S., Frigessi, A., Børresen-Dale, A.-L. and Kristensen , V.N.: Overrepresentation of
transcription factor families in the genesets underlying breast cancer subtypes; BMC Genomics
22;13(1):199, 2012.
390. Curtis C., Shah S.P., Chin S.-F., Turashvili G., Rueda O.M., Dunning M.J., Speed D., Lynch
A.G., Samarajiwa S., Yuan Y., METABRIC Group, Graf S., Ha G., Haffari G., Bashashati
A., Russell R., Mckinney S., langerød A., Green A., Provenzano E., Wishart G., Pinder S.,
Watson P., Markowetz F., Murphy L., Ellis I., Purushotham A., Børresen-Dale A.-L.,
Brenton J.D., Tavare´S., Caldas C. & Aparicio S.: The genomic and transcriptomic architecture of
2,000 breast tumours reveals novel subgroups. Nature, 486 (7403), 346-52, 2012.
391.Stephens, P.J., Tarpey P., Davies,H., Van Loo, P., Greenman, C., Varela,I., Zainal,S.N., Bignell,G.R.
Martin, S., Wedge,D.C., Beare,D., Butler,A., Cheverton,A., Gamble,J., Hinton, J., Jia, M.M.,
Jayakumar, A., Jones, D., Lattimer,C., Lau,K.W., McLaren,S., McBride,D., Menzies,A., Mudie,L.,
Kieran Raine,K., Teague,J., Easton,D.F., Langerod,A., OSBREAC Consortium, Broeks,A.,
Vargas,A.C., Turashvili,G., Martens,J.W.M., Aquila F., Chin,S.F., Thomas,G., Boyault,S.,
Mariani,O., Lakhani,S.R., van de Vijver,M., van 't Veer,L. Foekens,J.A., Desmedt,C., Sotiriou,C.,
Tutt,A., Caldas,C., Reis-Filho,J.S., Samuel AJR Aparicio,S.A.J.R., Salomon,A.V., BørresenDale, A.-L., Richardson,A.L., Campbell,P.J., P Andrew Futreal,P.A. and Stratton,M.R. The
landscape of cancer genes and mutational processes in breast cancer. Nature, 486 (7403), 400-4,
2012.
392. Lambrechts D, Truong T, Justenhoven C, Humphreys MK, Wang J, Hopper JL, Dite GS, Apicella C,
Southey MC, Schmidt MK, Broeks A, Cornelissen S, Hien RV, Sawyer E, Tomlinson I, Kerin M,
Miller N, Milne RL, Zamora MP, Pérez JI, Benítez J, Hamann U, Ko YD, Brüning T; The GENICA
Network, Chang-Claude J, Eilber U, Hein R, Nickels S, Flesch-Janys D, Wang-Gohrke S, John EM,
………. Kristensen V, Børresen-Dale A.-L, Devilee P, Tollenaar RA, Seynaeve CM, Hooning
MJ, García-Closas M, Chanock SJ, Lissowska J, Sherman ME, Hall P, Liu J, Czene K, Kang D, Yoo
KY, Noh DY, Lindblom A, Margolin S, Dunning AM, Pharoah PD, Easton DF, Guénel P, Brauch
H.: 11q13 is a Susceptibility Locus for Hormone Receptor Positive Breast Cancer. Hum Mutat, 33
(7), 1123-32, 2012.
393. Vachon CM, Scott CG, Fasching PA, Hall P, Tamimi RM, Li J, Stone J, Apicella C, Odefrey F,
Gierach GL, Jud SM, Heusinger K, Beckmann MW, Pollan M, Fernandez-Navarro P, GonzalezNeira A, Benítez J,…….. Kristensen VN, Børresen-Dale A.-L., Lindström S, Hankinson SE,
Hunter DJ, Andrulis IL, Knight JA, Boyd NF, Figueroa JD, Lissowska J, Wesolowska E, Peplonska
B, Bukowska A, Reszka E, Liu J, Eriksson L, Czene K, Audley T, Wu AH, Pankratz VS, Hopper
JL, Dos Santos Silva I.: Common Breast Cancer Susceptibility Variants in LSP1 and RAD51L1 Are
Associated with Mammographic Density Measures that Predict Breast Cancer Risk.
Cancer Epidemiol Biomarkers Prev, 21 (7), 1156-66, 2012.
394. Nik-Zainal S, Alexandrov LB, Wedge DC, van Loo P, Greenman CD, Raine K, Jones D, Hinton J,
Marshall J, Stebbing LA, Menzies A, Leung K, Chen L, Leroy C, Ramakrishna M, Rance R, Lau
KW, Mudie LJ, Varela I, Mcbride D, Bignell GR, Cooke S, Shlien A, Gamble J, Whittaker I,
Maddison M,…..Børresen-Dale, A.-L., Richardson A, Neuberger M, Futreal PA, Campell PJ and
Stratton, MR; Mutational Processes Moulding the Genomes of 21 Breast Cancer.
Cell, 149 (5), 979-93, 2012.
395. Nik-Zainal S, van Loo P, Wedge DC, Alexandrov LB, Greenman CD, Lau KW, Raine K, Jones D,
Marshall J, Ramakrishna M, Shlien A, Cooke S. Hinton J, Menzies A, Stebbings LA, Leroy C,
Jia M, Rance R, Mudie LJ, Gamble S, Stephens PJ, McLaren S, Tarpey PS, Papaemmanuil E,
Davies HR, Varela I, Mcbride D, Bignell GR Leung K, Butler AP, Teague JW,….Børresen-Dale
A.-L, Futreal PA, Stratton MR and Campbell PJ: The Life History of 21Breast Cancers.
Cell, 149 (5), 994-100, 2012.
396. Bilal E, Vassallo K, Toppmeyer D, Barnard N, Rye IH, Almendro V, Russnes H, Børresen-Dale A.L., Levine AJ, Bhanot G, Ganesan S. Amplified loci on chromosomes 8 and 17 predict early relapse
in ER-positive breast cancers. PLoS One. 2012;7(6):e38575. doi: 10.1371/journal.pone.0038575.
Epub 2012 Jun 13.
03.05.2017
7
397. Weishcer, M., Nordestgaard, B. G., Pharoah, P., Bolla, M. K., Nevanlinna, H., van’t
Veer, L. J…….Børresen-Dale, A.-L., Meyer, A., Easton, D. F., Schmidt, M. K. and Bojesen, S. E.
CHEK2*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death,
Breast Cancer–Specific Death, and Increased Risk of a Second Breast Cancer. J. Clin. Oncol.
(November 1) 30 (31): 2012
398. Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, SCHmidt MK, Broeks A,
Hogervorst FBL, Bueno-de-Mesquita B, Muir KR, Lophatananon A, Rattanamongkongul S,
Puttawibul P, Fasching P, Hein A, Ekici AB, Beckmann MW, Fletcher O, Johnson N, Silva IdS,
Peto J, Sawyer E,….. Børresen-Dale, A.-L.,….. Chang-Claude J, Easton DF and Dunning AM:
Comparison of the different 6q25 breast cancer hits from Asian and European Genome Wide
Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One, 7 (8), e42380,
2012
399. Borgan E, Lindholm EM, Moestue S, Mælandsmo GM, Lingjærde OC, Gribbestad IS, Børresen-Dale
A.-L., Engebraaten O, Sørlie T: Subtype-specific response to bevacizumab is reflected in the
metabolome and transcriptome of breast cancer xenograftsMol Oncol. 2013 Feb;7(1):130-42. doi:
10.1016/j.molonc.2012.10.005. Epub 2012 Oct 23.
400. Nilsen G, Liestøl K, Van Loo P, Moen Vollan HK, Eide MB, Rueda OM, Chin SF, Russell R,
Baumbusch LO, Caldas C, Børresen-Dale AL, Lingjaerde OC. Copynumber: Efficient algorithms
for single- and multi-track copy number segmentation. BMC
Genomics. 2012 Nov 4;13:591. doi:
10.1186/1471-2164-13-591.
401.Joshi H, Bhanot G, Børresen-Dale, A-L, Kristensen V.:
Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway
Br J Cancer. 2012 Nov 6;107(10):1722-8. doi: 10.1038/bjc.2012.461. Epub 2012 Oct 18.
402. Stavnes, H.T., Nymoen, D. A., Langerød, A., Holth, A., Børresen-Dale, A.-L. and Davidson, B.:
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous
carcinoma. Virchows Arch. 2013 Feb;462(2):163-73. doi: 10.1007/s00428-012-1347-3. Epub 2012
Dec 15
2013
403. Aure, M. R., Steinfeld, I., Baumbusch, L.O., Liestøl, K., Lipson, D., Nyberg, S., Naume, B., Sahlberg,
K. K., Kristensen, V. N., Børresen-Dale, A.-L., Lingjærde, O.C. and Yakhini, S.: Identifying in-
trans process associated genes in breast cancer by integrated analysis of copy number and
expression data PLoS One. 2013;8(1):e53014. doi: 10.1371/journal.pone.0053014. Epub 2013 Jan
30.
404. Sahlberg, K. K., Hongisto, V., Edgren, H., Mäkelä, R., Hellström, K., Due, E. U., Vollan, H. K.,
Sahlberg, N., Wolf, M., Børresen-Dale, A.-L., Perälä and Kallioniemi, O.:The HER2 amplicon
includes several genes required for the growth and survival of HER2 positive breast cancer cells.
Mol Oncol. 2013 Jun;7(3):392-401. doi: 10.1016/j.molonc.2012.10.012. Epub 2012 Nov 24.
405.Baumbusch, L.O., Helland, Å., Wang, Y., Liestøl, K., Schaner, M. E., Holm, R., Etemadmoghadam, D.,
Alsop, K., Brown, P., Australian Ovaian Cancer Study Group., Mitchell, G., Fereday, S., DeFazio,
A., Bowtell, D.D.L., Kristensen, G. B., Lingjærde, O.C. and Børresen-Dale, A.-L.: High Levels of
Genomic Aberrations in Serous Ovarian Cancers are Associated with Better Survival. PLoS One.
2013;8(1):e54356. doi: 10.1371/journal.pone.0054356. Epub 2013 Jan 23.
406. Margolin, A. A., Bilal, E., Huang, E., Norman, T.C., Ottestad, L., Mecham, B. H., Sauerwine, B.,
Kellen, M. R., Mangravite, L. M., Furia, M. d., Vollan, H.K.M., Rueda, O. M., Guinney, J.,
Deflaux, N.A., Hoff, B., Schildwachter, X., Russnes, H. G., Park, D., Vang, V.O., Pirtle, t., Youseff,
L., Citro, C., Curtis, C., The Sage DREAM Breast Cancer Challenge Consortium, Kristensen, V.N.,
Hellerstein, J., Friend, S.H., Stolovitzky, G., Aparacio, S., Caldas, C. and Børresen-Dale, A.-L.:
Systematic Analysis of Challenge-Driven Improvements in Molecular Prognostic Models for Breast
Cancer. Sci Transl Med. 2013 Apr 17;5(181):181re1. doi: 10.1126/scitranslmed.3006112.
03.05.2017
8
407. Bilal, E., Dutkowski, J., Guinney, J., Jang, I.S., Logsdon, B. A., Pandey, G., Sauerwine, B. A.,
Shimoni, Y., Vollan, H.K.R., mecham, B. H., Rueda, O. M., Tost, J., Curtis, C., Alvarez, M., J.,
Kristensen, V. N., Aparicio, S., Børresen-Dale, A.-L., Caldas, C., Califano, A., Friend, S. H.,
Ideker, T., Schadt, E. E., Stolovitzky, G. A. and Margolin, A. A.: Improving Breast Cancer Survival
Analysis Through Competition-Based Multidimensional Modeling. PLOS Computational Biology,
PLoS Comput Biol. 2013 May;9(5):e1003047. doi:10.1371/journal.pcbi.1003047 Epub 2013 May9.
408. Edvardsen, H., Landmark-Høyvik, H., Reinertsen, K. V., Zhao, X., Grenaker-Alnæs, G. I., Nebdal, D.,
Syvänen, A-Chr., Rødningen, O., Alsner, J., Overgaard, J., Børresen-Dale, A.-L., Fosså, S. D. and
Kristensen, V.N.: SNP in TXNRD2 Associated to Radiation-Induced Fibrosis: A Study of Genetic
Variation in Reactive Oxygen Species Metabolism and Signaling. Int J Radiat Oncol Biol Phys.
2013 Jul 15;86(4):791-9. doi: 10.1016/j.ijrobp.2013.02.025. Epub 2013 Apr 16
409. Myhre, S., Lingjærde, O.C., Hennessy, B. T., Aure, M. R., Carey, M. S., Alsner, J., Tramm, T.,
Overgaard, J., Mills, G. B., Børresen-Dale, A.-L. and Sørlie, T.: Influence of DNA copy number
and mRNA levels on the expression of breast cancer related proteins. Mol Oncol. 2013
Jun;7(3):704-18. doi: 10.1016/j.molonc.2013.02.018. Epub 2013 Mar 19.
410. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio S, Behjati S, Biankin AV, Bignell GR, Bolli N,
Borg A, Børresen-Dale AL................. Pfister SM, Campbell PJ, and Stratton MR: Signatures of
mutational processes in human cancer. Nature. 2013 Aug 22;500(7463):415-21. doi:
10.1038/nature12477. Epub 2013 Aug 14.
411. Rajaram, M., Zhang, J., Wang, T., Li,J., Kuscu, C., Qi, H., Kato,M., Grubor, V., Weil, R.J., Helland,
Å., Børrensen-Dale, A.-L., Cho, K.R., Levine, D.A., Houghton, A.N., Wolchok, J.D., Myeroff, L.,
Markowitz, S., Lowe, S.W., Zhang,M., Krasnitz,A., Lucito, R., Mu, D. and Scott Powers, R.: Two
Distinct Categories of Focal Deletions in Cancer Genomes. PLOS One, June 2013, 8 (6). Epub
e66264
412. Klajic J, Fleischer T, Dejeux E, Edvardsen H, Warnberg F, Bukholm I, Lønning PE, Solvang H,
Børresen-Dale AL, Tost J, Kristensen VN (2013)
Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to
clinico-pathological factors in breast tumors BMC Cancer, 13, 456
PubMed 24093668
413. Kalous O, Conklin D, Desai AJ, Dering J, Goldstein J, Ginther C, Anderson L, Lu M, Kolarova T,
Eckardt MA, Langerød A, Børresen-Dale AL, Slamon DJ, Finn RS (2013)
AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell
lines with dysfunctional p53 Breast Cancer Res Treat, 141 (3), 397-408 PubMed 24091768
414. Landmark-Høyvik H, Dumeaux V, Nebdal D, Lund E, Tost J, Kamatani Y, Renault V, BørresenDale AL, Kristensen V, Edvardsen H (2013) Genome-wide association study in breast cancer
survivors reveals SNPs associated with gene
expression of genes belonging to MHC class I and II
Genomics, 102 (4), 278-87 PubMed 23880221
415. Møller EK, Kumar P, Voet T, Peterson A, Van Loo P, Mathiesen RR, Fjelldal R, Grundstad J, Borgen
E, Baumbusch LO, Naume B, Børresen-Dale AL, White KP, Nord S, Kristensen VN (2013)
Next-generation sequencing of disseminated tumor cells Front Oncol. 2013 Dec 31;3:320. doi:
10.3389/fonc.2013.00320. eCollection 2013.PMID:24427740[PubMed]
416. Meyer KB, O'Reilly M, Michailidou K, Carlebur S, Edwards SL, French JD, Prathalingham R, Dennis
J, Bolla MK, Wang Q, de Santiago I, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Schmidt
MK, Broeks A, Van 't Veer LJ, Hogervorst FB, Muir K, Lophatananon A, Stewart-Brown S,
Siriwanarangsan P, Fasching PA, Lux MP…….Børresen-Dale, A-L et al. (2013)
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially
bind FOXA1 and E2F1 Am J Hum Genet, 93 (6), 1046-60 PubMed 24290378
03.05.2017
9
2014
417. Tahiri A, Leivonen SK, Lüders T, Steinfeld I, Ragle Aure M, Geisler J, Mäkelä R, Nord S, Riis ML,
Yakhini Z, Kleivi Sahlberg K, Børresen-Dale AL, Perälä M, Bukholm IR, Kristensen VN (2014)
Deregulation of cancer-related miRNAs is a common event in both benign and malignant human
breast tumors. Carcinogenesis, 35 (1), 76-85, PubMed 24104550
418. Leivonen SK, Sahlberg KK, Mäkelä R, Due EU, Kallioniemi O, Børresen-Dale AL, Perälä M (2014)
High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth
Mol Oncol, 8 (1), 93-104 PubMed 24148764
419. Liu Y, Zhou R, Baumbusch LO, Tsavachidis S, Brewster AM, Do KA, Sahin A, Hortobagyi GN,
Taube JH, Mani SA, Aarøe J, Wärnberg F, Børresen-Dale AL, Mills GB, Thompson PA, Bondy
ML (2014) Genomic copy number imbalances associated with bone and non-bone metastasis of
early-stage breast cancer Breast Cancer Res Treat, 143 (1), 189-201 PubMed 24305980
420.Almendro V, Cheng YK, Randles A, Itzkovitz S, Marusyk A, Ametller E, Gonzalez-Farre X, Muñoz
M, Russnes HG, Helland A, Rye IH, Borresen-Dale AL, Maruyama R, van Oudenaarden A,
Dowsett M, Jones RL, Reis-Filho J, Gascon P, Gönen M, Michor F, Polyak K:
Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ
Analysis of Genetic and Phenotypic Cellular Diversit. Cell Rep. 2014 Feb 13;6(3):514-27. doi:
10.1016/j.celrep.2013.12.041. Epub 2014 Jan 23. PMID:24462293[PubMed - in process]
421. Milne RL, Herranz J, Michailidou K, Dennis J, Tyrer JP, Zamora MP, Arias-Perez JI, González-Neira
A, Pita G, Alonso MR, Wang Q, Bolla MK, Czene K, Eriksson M, Humphreys K, Darabi H, Li J,
Anton-Culver H, Neuhausen SL, Ziogas A, Clarke CA, Hopper JL, Dite GS, Apicella C, Southey
MC……Børresen-Dale, A-L et al.: A large-scale assessment of two-way SNP interactions in breast
cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association
consortium Hum Mol Genet. 2014 Apr 1;23(7):1934-46. doi: 10.1093/hmg/ddt581. Epub 2013 Nov
15. PubMed 24242184
423.Fleischer T, Edvardsen H, Solvang HK, Daviaud C, Naume B, Børresen-Dale AL, Kristensen VN, Tost
J. Integrated analysis of high-resolution DNA methylation profiles, gene expression, germline
genotypes and clinical end points in breast cancer patients Int J Cancer. 2014 Jun
1;134(11):2615-25. doi: 10.1002/ijc.28606. Epub 2014 Jan 6. PubMed 24395279
424. Silwal-Pandit L, Moen Vollan HK, Chin SF, Rueda OM, McKinney SE, Osako T, Quigley D,
Kristensen VN, Aparicio S, Borresen-Dale AL, Caldas C, Langerod A: TP53 mutation spectrum in
breast cancer is subtype specific and has distinct prognostic relevance. Clin Cancer Res. 2014 May
6. [Epub ahead of print] PMID:24803582
425.Saldova R, Asadi Shehni A, Haakensen VD, Steinfeld I, Hilliard M, Kifer I, Helland A, Yakhini Z,
Børresen-Dale AL, Rudd PM. Association of N-Glycosylation with Breast Carcinoma and
Systemic Features Using High-Resolution Quantitative UPLC. J Proteome Res. 2014 Apr 11. [Epub
ahead of print] PMID:24669823[PubMed - as supplied by publisher]
426.Grinde MT, Skrbo N, Moestue SA, Rødland EA, Borgan E, Kristian A, Sitter B, Bathen TF,
Børresen-Dale AL, Mælandsmo GM, Engebraaten O, Sørlie T, Marangoni E, Gribbestad IS
Interplay of choline metabolites and genes in patient-derived breast cancer xenografts
Breast Cancer Res. 2014 Jan 21;16(1):R5. [Epub ahead of print] PMID:24447408[PubMed - as
supplied by publisher]
427. Quigley DA, Fiorito E, Nord S, Van Loo P, Alnæs GG, Fleischer T, Tost J, Moen Vollan HK, Tramm
T, Overgaard J, Bukholm IR, Hurtado A, Balmain A, Børresen-Dale AL, Kristensen V:
The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive
tumors Mol Oncol (in press) PubMed 24388359
03.05.2017
10
428. Aure MR, Leivonen SK, Fleischer T, Zhu Q, Overgaard J, Alsner J, Tramm T, Louhimo R, Alnæs GI,
Perälä M, Busato F, Touleimat N, Tost J, Børresen-Dale AL, Hautaniemi S, Troyanskaya OG,
Lingjærde OC, Sahlberg KK, Kristensen VN Individual and combined effects of DNA methylation
and copy number alterations on miRNA expression in breast tumors Genome Biol, 14 (11), R126 (in
press) PubMed 24257477
429. Bjaanaes MM, Halvorsen AR, Solberg S, Jørgensen L, Dragani TA, Galvan A, Colombo F, Anderlini
M, Pastorino U, Kure E, Børresen-Dale AL, Brustugun OT, Helland A. Unique microRNA-profiles
in EGFR-mutated lung adenocarcinomas Int J Cancer. 2014 Mar 6. doi: 10.1002/ijc.28828. [Epub
ahead of print] PMID:24599520[PubMed - as supplied by publisher]
430. Zhao X, Rødland EA, Sørlie T, Vollan HKM, Russnes HG, Kristensen VN, Lingjærde OC, BørresenDale A-L: Systematic assessment of prognostic gene signatures for breast cancer shows distinct
influence of time and ER status Journal: BMC Cancer BMC Cancer. 2014 Mar 19;14:211. doi:
10.1186/1471-2407-14-211.PMID:24645668[PubMed - in process]
431.Cooke SL, Shlien A, Marshall J, Pipinikas CP, Martincorena I, Tubio JM, Li Y, Menzies A, Mudie L,
Ramakrishna M, Yates L, Davies H, Bolli N, Bignell GR, Tarpey PS, Behjati S, Nik-Zainal S,
Papaemmanuil E, Teixeira VH, Raine K, O'Meara S, Dodoran MS, Teague JW, Butler AP,
Iacobuzio-Donahue C, Santarius T, Grundy RG, Malkin D, Greaves M, Munshi N, Flanagan AM,
Bowtell D, Martin S, Larsimont D, Reis-Filho JS, Boussioutas A, Taylor JA, Hayes ND, Janes SM,
Futreal PA, Stratton MR, McDermott U, Campbell PJ; ICGC Breast Cancer Group. Processed
pseudogenes acquired somatically during cancer development. Nat Commun. 2014 Apr 9;5:3644.
doi: 10.1038/ncomms4644. PMID:24714652[PubMed - in process]
432.Halvorsen AR, Helland A, Fleischer T, Haug KM, Grenaker Alnaes GI, Nebdal D, Syljuåsen RG,
Touleimat N, Busato F, Tost J, Saetersdal AB, Børresen-Dale AL, Kristensen V, Edvardsen H.
Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in
radiation therapy Int J Cancer. 2014 Mar 24. doi: 10.1002/ijc.28862. [Epub ahead of print]
PMID:24658971[PubMed - as supplied by publisher]
In press
433. Sørlie T, Johnsen H, Vu P, Lind GE, Lothe R, Børresen-Dale AL.:Mutation screening of the TP53
gene by temporal temperature gel electrophoresis (TTGE). Methods Mol Biol. 2014;1105:315-24.
doi: 10.1007/978-1-62703-739-6_25. PMID:24623239[PubMed - in process]
434.Nygren MK, Tekle C, Ingebrigtsen VA, Mäkelä R, Krohn M, Aure MR, Nunes-Xavier CE, Perälä M,
Tramm T, Alsner J, Overgaard J, Nesland JM, Borgen E, Børresen-Dale AL, Fodstad Ø, Sahlberg
KK, Leivonen SK. Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of
microRNA-29c. Br J Cancer. 2014 Apr 15;110(8):2072-80. doi: 10.1038/bjc.2014.113. Epub 2014
Feb 27.PMID:24577056[PubMed - in process]
435. Askautrud HA, Gjernes E, Gunnes G, Sletten M, Ross DT, Børresen-Dale AL, Iversen N, Tranulis
MA, Frengen E: Global gene expression analysis reveals a link between NDRG1 and vesicle
transport. PLoS One. 2014 Jan 31;9(1):e87268. doi: 10.1371/journal.pone.0087268. eCollection
2014.PMID:24498060 [PubMed - in process]
436.Sternemalm J, Russnes HGR, Zhao X, Risberg B, Nord S, Caldas S, Børresen-Dale AL, Stokke T.
and Patzke S.: Nuclear CSPP1 expression defined subtypesof basal-like breast cancer, BJC, in press
437.Tubio JMC, Li Y, Ju YS, Martincorena I, Cooke SL, Tojo M ……Børresen-Dale AL…..and Peter J.
Campbell, P.J: Title: Extensive transduction of non-repetitive DNA mediated by L1
retrotransposition in cancer genomes. Science, in press
438. Johnson N, Dudbridge F, Orr N, Gibson L …...................Kristensen VN, Alnæs GIG,
Børresen-Dale AL…… Fletcher O: Genetic variation at CYP3A is associated with age at
menarche and breast cancer risk: a case-control study. Breast Cancer Research, in press
03.05.2017
11
B. Chapters in books, invited reviews, and scientific comments
B31. Lönneborg, A., Aarøe, J., Dumeaux, V., and Børresen-Dale, A.-L.: Found in translation: gene
expression and other novel blood biomarkers for the early detection of breast cancer. Expert Rev
Anticancer Ter. 2009 Aug;9(8):1115-23.
B32. Perou, C. M. and Børresen-Dale, A.-L.: System biology and genomics – gene expression analysis. In:
The Biology of the Mammary Gland. Ed. M. Bissell, K. Polyak and J. Rosen, CSH Perspect.Biol.
2010 Nov.3.
B33. Kristensen, V. N. and Børresen-Dale, A.-L.: On the molecular biology of breast cancer. In Special
Issue of Mol Oncol, Eds.: Kristensen, V. N., Sørlie, T. and Børresen-Dale, A.-L. Mol Oncol.
4(3):171-3, 2010.
B34. Pado, F., Buydens, L. M. C., Degani, H., Hilhorst, R., Klipp, E., Gribbestad, I. S., Huffel, S.,
Laarhoven, H. W. M., Luts, J., Monelon, D., Postma, G. J., Schneiderhan-Marra, N., Santoro, F.,
Wouters, H., Russnes, H. G., Sørlie, T., Tagliabue, E. and Børresen-Dale, A.-L. for the FEMME
consortium. Triple-negative breast cancer: Present challenges and new perspectives. . In Special
Issue of Mol Oncol, Eds.: Kristensen, V. N., Sørlie, T. and Børresen-Dale, A.-L.
Mol Oncol. 4(3):209-29, 2010.
B35. Kristensen, V.N. and Børresen-Dale, A.-L.: Mutations for the people. EMBO Mol Med. 2, 143-145,
2010.
B36. International network of cancer genome projects. International Cancer Genome Consortium:
Nature 464 (7291): 993-8, 2010.
B37. Loo PV, Nilsen G, Nordgard SH, Vollan HK, Børresen-Dale, A.-L., Kristensen VN, Lingjærde OC.
Next Generation microarray bioinformatics. Chapter 4: Analyzing cancer samples with SNP arrays.
Methods Mol Biol. 2012;802:57-72
B38. Zhao, X., Lingjærde, O. Ch. and Børresen-Dale, A.-L.: Breast Cancer Prognostication and Risk
Prediction in the Post-Genomic Era. The Continuum of Health Risk Assessments, ISBN 980-953307-582-7. Published online, 2012. http://www.intechopen.com/articles/show/title/breast-cancerprognostication-and-risk-prediction-in-the-post-genomic-era
B39. Engebraaten, Vollan, H.K.M., and Børresen-Dale, A.L.:
Triple-negative breast cancer and the need for new therapeutic targets. Am J Pathol. 2013
Oct;183(4):1064-74. doi: 10.1016/j.ajpath.2013.05.033. Epub 2013 Aug 3.
B40. Kristensen VN, Lingjærde OC, Russnes HG, Vollan HK, Frigessi A, Børresen-Dale AL.
Principles and methods of integrative genomic analyses in cancer. Nat Rev Cancer. 2014
May;14(5):299-313. doi: 10.1038/nrc3721.PMID:24759209[PubMed - in process]
C. Scientific articles in Nordic journals and books and popular articles.
C33. Ikdahl, T., Børresen-Dale, A.-L., Helland, Å. and Haakensen, V.: Tumorbiologi. In: Kreftsykdommer
Eds: Kåresen, R and Wist, E. , Rev. 4. .Gyldendal Norsk Forlag, 2012.
D. Scientific consortium papers (ALBD is a key member of the consortia);
WECARE (Women's Environmental Cancer and Radiation Epidemiology)
Mutp53 ( Mutant p53 in cancer Consortium)
D6. Langholz, B., Thomas, C. C., Stovall, M., Smith, S. A., Boice, J. D., Jr., Shore, R. E., Bernstein, L.,
Lynch, C. F., Zhang, X., Bernstein, J. L.: Statistical methods for analysis of radiation effects with
03.05.2017
12
tumor and dose location-specific information with application to the WECARE study o
fasynchronous contralateral breast cancer. Biometrics. Biometrics. 65(2):599-608, 2009.
D7. Poynter, J. N., Langholz, B., Lagent, J., Mellemkjaer, L., Bernstein, L., Malone, K. E., Lynch, C. F.,
Borg, A., Concannon, P., Teraoka, S.N., Xue, S, Diep, A. T., Törngren, T., Begg, C. B., Capanu, M.,
Haile, R. W; WECARE study Collaborative group, Bernstein J.L.: Reproductive factors and risk of
contralateral breast cancer by BRCA1 and BRCA2 mutation status results from the WECARE study.
Cancer Causes Control 21(6): 839-46, 2010.
D8. Tischkowitz M, Capanu M, Sabbaghian N, Li L, Liang X, Vallée MP, Tavtigian SV, Concannon P,
Foulkes WD, Bernstein L; WECARE Study Collaborative Group, Bernstein, JL, Begg CB. Rare
germline mutations in PALB2 and breast cancer risk: a population-based study. Hum Mutat. 2012
Apr;33(4):674-80. doi: 10.1002/humu.22022. Epub 2012 Feb 15.
03.05.2017
13